Abstract：
:High-throughput, human cell-based applications of RNA-mediated interference (RNAi) have emerged in recent years as perhaps the most powerful of a 'second wave' of functional genomics technologies. The available reagents and methodologies for RNAi screening studies now enable a wide range of different scopes and scales of investigation, from single-parameter assays applied to focused subsets of genes, to comprehensive genome-wide surveys based on rich, multiparameter readouts. As such, RNAi-based screens are offering important new avenues for the discovery and validation of novel therapeutic targets for several disease areas, including oncology. By enabling a 'clean' determination of gene function, that is the creation of direct causal links between gene and phenotype in human cells, RNAi investigations promise levels of pathophysiological relevance, efficiency, and range of applicability never before possible on this scale. The field of oncology, with its many assays using readily transfectable cell lines, has offered particularly fertile ground for showcasing the potential of RNAi-based genomics. However, like any other technology before it, RNAi is not without its own challenges, limitations, and caveats. Many of these issues stem directly from the choice of silencing reagent to be used in such studies, and the design of the overall screening strategy. Here, we discuss the basic design issues, potential advantages, and technical challenges of large-scale RNAi screens based on the use of chemically synthesized siRNA libraries.
journal_name
Oncogenejournal_title
Oncogeneauthors
Sachse C,Echeverri CJdoi
10.1038/sj.onc.1208072subject
Has Abstractpub_date
2004-11-01 00:00:00pages
8384-91issue
51eissn
0950-9232issn
1476-5594pii
1208072journal_volume
23pub_type
杂志文章,评审相关文献
ONCOGENE文献大全abstract：:Previous work has demonstrated that E2F proteins regulate the expression of various genes encoding proteins essential for DNA replication and cell-cycle progression. E2F1 in particular is required for the initial entry to the cell cycle from a quiescent state and is required for the activation of other E2F genes. Othe...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2008.55
更新日期：2008-07-10 00:00:00
abstract：:There have been few studies on the specific signaling pathways involved in the transformation of epithelial cells by oncogenic protein tyrosine kinases. Here we investigate the requirement of MAP (MAPK) and phosphatidylinositol 3- (PI3K) kinases in the transformation of rat intestinal epithelial (RIE) cells by oncogen...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1203911
更新日期：2000-11-09 00:00:00
abstract：:Expression of the c-myc gene is often elevated in human colorectal tumors, but reported amplification of the locus is rare. Here we demonstrate that modest amplification of c-myc is frequently found in aggressive subtypes of colorectal cancer. Careful quantitation of c-myc copy number has shown amplification in 53.8% ...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1991-01-01 00:00:00
abstract：:The c-Myb, A-Myb and B-Myb transcription factors have nearly identical DNA-binding domains, activate the same reporter gene constructs in animal cells, but have different biological roles. The Myb proteins are often coexpressed in the same cells, raising questions about whether they activate similar or distinct gene e...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206131
更新日期：2003-01-16 00:00:00
abstract：:Mcl-1 is an antiapoptotic member of the Bcl-2 family that can promote cell viability. We report here that Mcl-1 is a new substrate for caspases during induction of apoptosis. Mcl-1 cleavage occurs after Asp127 and Asp157 and generates four fragments of 24, 19, 17 and 12 kDa in both intact cells and in vitro, an effect...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208069
更新日期：2004-10-14 00:00:00
abstract：:In this study we have surveyed by immunoblotting the protein levels of Cyclin D1, D2, D3 and their catalytic partners, Cdk4 and Cdk6 in normal and transformed human cells. We found that all these proteins were differentially expressed in diploid cells derived from different tissues, in contrast to Cyclin E, Cyclin A a...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-09-01 00:00:00
abstract：:Despite the recent success of MAPK signaling-targeted drugs in melanoma, the majority of patients with metastatic melanoma still undergo disease progression after initial tumor shrinkage indicating gradually developing therapy resistance. This review will give an overview on currently suggested concepts of resistance ...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/onc.2014.249
更新日期：2015-06-04 00:00:00
abstract：:Histone deacetylase inhibitors (HDACis) are a promising class of anticancer epigenetic drugs, however, molecular factors influencing the responses of individual tumors to HDACi therapies remain obscure. Here, we sought to identify genes associated with HDACi resistance in gastric cancer. Treating a panel of 17 gastric...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2013.104
更新日期：2014-03-20 00:00:00
abstract：:The natural phytoalexin resveratrol (3, 5, 4'-trihydroxystilbene) exhibits both chemopreventive and antitumor activities through a variety of mechanisms. We have shown previously that resveratrol-induced apoptosis of a human colon cancer cell line involved the redistribution of CD95 (Fas/Apo-1) into lipid rafts. Here,...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208086
更新日期：2004-11-25 00:00:00
abstract：:p27Kip1 plays an important role in cell cycle progression by negatively regulating the activity of cyclin-Cdk complexes. To understand how p27Kip1 functions, the level and subcellular location of p27Kip1 in Swiss/3T3 cells following serum stimulation of quiescent cells was examined. Surprisingly, p27Kip1 was observed ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202912
更新日期：1999-09-16 00:00:00
abstract：:Promyelocytic leukemia (PML) nuclear bodies (PML NBs) are discrete subnuclear domains organized by the promyelocytic leukemia protein PML, a tumor suppressor essential for multiple apoptotic pathways. We have recently described a novel family of cellular factors, the THAP proteins, characterized by the presence at the...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206271
更新日期：2003-04-24 00:00:00
abstract：:Knowledge of tumour initiation in human epithelia is limited by sample availability and difficulty in experimental manipulation of human cells. The thyroid is a useful model since, in addition to multiple tumour stages, it presents two distinct 'pathways' of tumorigenesis: 'follicular' tumours, in which ras oncogene m...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1994-01-01 00:00:00
abstract：:Malignant tumors are exemplified by excessive proliferation and aggressive migration/invasion contributing to increased mortality of cancer patients. Matrix metalloproteinase 9 (MMP9) expression is positively correlated with lung cancer malignancy. The mechanism underlying an elevated MMP9 expression is not clearly de...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2015.14
更新日期：2015-10-29 00:00:00
abstract：:The specific chromosomal translocation t(9;22)(q22-31;q11-12) has been observed in the myxoid variant of human chondrosarcoma. In agreement with this observation we report that the EWS gene located at chromosome band 22q12 becomes fused to CHN, a member of the steroid/thyroid receptor gene superfamily located at 9q22-...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1996-01-18 00:00:00
abstract：:Cbl proteins are ubiquitin protein ligases, which ubiquitinate activated tyrosine kinases and target them for degradation. Both c-Cbl and Cbl-b have an ubiquitin associated (UBA) domain at their C-terminal end. We observed that high molecular weight ubiquitinated proteins constitutively coimmunoprecipitated with trans...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1207952
更新日期：2004-09-16 00:00:00
abstract：:Fas signaling was reported to participate in cell apoptosis. However, this pathway has also been shown to promote tumor cell motility, leading to the hypothesis that Fas signaling may induce epithelial-mesenchymal transition (EMT) to promote metastasis. The effects of Fas-ligand (FasL) treatment and inhibition of Fas ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2012.126
更新日期：2013-02-28 00:00:00
abstract：:A two-stage (initiation and promotion) model of chemical transformation of mouse embryonic fibroblasts was used to elucidate the molecular mechanisms of tumor promotion in vitro. C3H10T1/2 cells which had been initiated with a subcarcinogenic dose (0.5 micrograms ml-1) of benzo[a]pyrene (B[a]P) were isolated after 12-...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1992-11-01 00:00:00
abstract：:c-Myc overexpression has been associated with several types of human cancers. To study the role of c-myc in epidermal differentiation and carcinogenesis, a transgenic mouse model was created to overexpress c-Myc in the epidermis. Human c-myc 2 cDNA was subcloned into a 6.5 kb mouse loricrin expression vector, ML.myc2....
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1203040
更新日期：1999-08-26 00:00:00
abstract：:Aurora kinases are known to play a key role in maintaining mitotic fidelity, and overexpression of aurora kinases has been noted in various tumors. Overexpression of aurora kinase activity is thought to promote cancer development through a loss of centrosome or chromosome number integrity. Here we observed augmentatio...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1208293
更新日期：2005-02-03 00:00:00
abstract：:The p53 oncosuppressor is strictly maintained in an inactive form under normal conditions, while it is post-translationally activated by a variety of stresses, enacting different protective biological functions. Since one critical issue in cancer gene therapy is tumor specificity, we asked whether the tight p53 regula...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1207042
更新日期：2004-01-15 00:00:00
abstract：:Chromosomal aberrations are a hallmark of human cancers, with complex cytogenetic rearrangements leading to genetic changes permissive for cancer initiation and progression. Protection of Telomere 1 (POT1) is an essential component of the shelterin complex and functions to maintain chromosome stability by repressing t...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2016.405
更新日期：2017-04-06 00:00:00
abstract：:Loss of p53 function is associated with the acquisition of cisplatin resistance in the human ovarian adenocarcinoma A2780 cell line. Selection for cisplatin resistance of A2780 cells was used to isolate genetic suppressor elements (GSEs) from a retroviral library expressing random fragments of human or murine TP53 cDN...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1200813
更新日期：1997-01-16 00:00:00
abstract：:A wealth of cytogenetic data has demonstrated that numerous somatic genetic changes are involved in the pathogenesis of human lung cancer. Despite the complexity of the genomic changes observed in these neoplasms, recurrent chromosomal patterns have emerged. In this review, we summarize chromosomal alterations identif...
journal_title：Oncogene
pub_type： 杂志文章,评审
doi：10.1038/sj.onc.1205836
更新日期：2002-10-07 00:00:00
abstract：:Several motifs are conserved in the extracellular domain of the cloned chains of the recently described cytokine receptor superfamily. One of them, usually close to the transmembrane region, is the 'WS motif'. Its function remains unknown, but it has been recently shown that the integrity of this motif is essential fo...
journal_title：Oncogene
pub_type： 杂志文章
doi：
更新日期：1993-03-01 00:00:00
abstract：:Colorectal cancer is a major cause of cancer deaths in Western countries, but epidemiological data suggest that dietary modification might reduce these by as much as 90%. Cyclo-oxygenase 2 (COX2), an inducible isoform of prostaglandin H synthase, which mediates prostaglandin synthesis during inflammation, and which is...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202980
更新日期：1999-10-28 00:00:00
abstract：:P53 is a tumor suppressor gene that plays a crucial role in suppressing tumorigenesis by inducing either cell cycle arrest or apoptosis in cells with DNA damage. In more than 50% of tumors p53 is inactivated by gene mutations. However, there have also been reports of tumor cells in which p53 remains wild type and is p...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210110
更新日期：2007-05-10 00:00:00
abstract：:The cysteine protease cathepsin B (CTSB) is frequently overexpressed in human breast cancer and correlated with a poor prognosis. Genetic deficiency or pharmacological inhibition of CTSB attenuates tumor growth, invasion and metastasis in mouse models of human cancers. CTSB is expressed in both cancer cells and cells ...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/onc.2013.395
更新日期：2014-09-04 00:00:00
abstract：:The precise genetic mechanism of malignant transformation in DNA mismatch repair deficient, microsatellite-unstable colorectal cancer (CRC) has yet to be elucidated. We employed cDNA microarray to identify patterns of gene expression among CRC cell lines and to compare directly lines with and without microsatellite in...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1206609
更新日期：2003-09-18 00:00:00
abstract：:Most human lymphomas originate from transformed germinal center (GC) B lymphocytes. While activating mutations and translocations of MYC, BCL2 and BCL6 promote specific GC lymphoma subtypes, other genetic and epigenetic modifications that contribute to malignant progression in the GC remain poorly defined. Recently, a...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1210211
更新日期：2007-06-21 00:00:00
abstract：:The gfi-1 gene encodes a zinc finger containing protein that is specifically expressed in T-lymphocytes and is a frequent target of proviral insertion in T-cell lymphoma provoked by infection with MoMuLV--a non acute transforming retrovirus. Expression of a gfi-1 transgene targeted to T-cells by the lck proximal promo...
journal_title：Oncogene
pub_type： 杂志文章
doi：10.1038/sj.onc.1202191
更新日期：1998-11-19 00:00:00
